These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9260370)

  • 1. Acute toxicities and feasibility of altered fractionated radiotherapy in nasopharyngeal carcinoma.
    Chang JT; Chen LH; Tang SG; Liao CT; Chen WC; Leung WM; Wang CH; Hsui-Tsai M
    Changgeng Yi Xue Za Zhi; 1997 Jun; 20(2):107-14. PubMed ID: 9260370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late course accelerated hyperfractionated radiotherapy of nasopharyngeal carcinoma (LCAF).
    He XY; Liu TF; He SQ; Huan SL; Pan ZQ
    Radiother Oncol; 2007 Oct; 85(1):29-35. PubMed ID: 17889386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase III study of late course accelerated hyperfractionated radiotherapy versus conventionally fractionated radiotherapy in patients with nasopharyngeal carcinoma.
    Pan ZQ; He XY; Guo XM; Ye M; Zhang Z; He SQ; Liu TF
    Am J Clin Oncol; 2012 Dec; 35(6):600-5. PubMed ID: 22134512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperfractionated radiotherapy in locally advanced nasopharyngeal cancer. An analysis of 43 consecutive patients.
    Jereczek-Fossa BA; Morra A; DeBraud F; Alterio D; Mazzetta C; Rocca A; Catalano G; Bianchi L; Pasetti M; Chiesa F; Bruschini R; Orecchia R
    Strahlenther Onkol; 2004 Jul; 180(7):425-33. PubMed ID: 15241530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: an evaluation of response and toxicity.
    Lu JJ; Shakespeare TP; Thiagarajan A; Zhang X; Liang L; Tan S
    Laryngoscope; 2005 May; 115(5):806-10. PubMed ID: 15867644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
    Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
    Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy.
    Chang JT; Lin CY; Chen TM; Kang CJ; Ng SH; Chen IH; Wang HM; Cheng AJ; Liao CT
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1354-60. PubMed ID: 16297716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different risks of symptomatic brain necrosis in NPC patients treated with different altered fractionated radiotherapy techniques.
    Jen YM; Hsu WL; Chen CY; Hwang JM; Chang LP; Lin YS; Su WF; Chen CM; Liu DW; Chao HL
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):344-8. PubMed ID: 11567807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
    Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
    Thiagarajan A; Lin K; Tiong CE; Tan LK; Loh TK; Goh BC; Lu JJ
    Laryngoscope; 2006 Jun; 116(6):938-43. PubMed ID: 16735885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-irradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy.
    Chua DT; Sham JS; Leung LH; Au GK
    Radiother Oncol; 2005 Dec; 77(3):290-4. PubMed ID: 16289398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience in fractionated stereotactic body radiation therapy boost for newly diagnosed nasopharyngeal carcinoma.
    Chen HH; Tsai ST; Wang MS; Wu YH; Hsueh WT; Yang MW; Yeh IC; Lin JC
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1408-14. PubMed ID: 17126207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a prospective randomised trial comparing conventional radiotherapy to split course bifractionated radiation therapy in patients with nasopharyngeal carcinoma.
    Daoud J; Toumi N; Siala W; Ghorbel A; Drira MM; Frikha M
    Radiother Oncol; 2007 Oct; 85(1):17-23. PubMed ID: 17343938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
    Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy.
    Kong L; Lu JJ; Hu C; Guo X; Wu Y; Zhang Y
    Cancer; 2006 Sep; 107(6):1287-93. PubMed ID: 16909425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of quadruple fluid aerosol inhalation on oral mucositis induced by radiotherapy in nasopharyngeal carcinoma and its mechanism].
    Chen J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):527-30. PubMed ID: 17611340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.